If REITs were players’ pieces on a Monopoly game board, then they all just drew the equivalent to an “Advance to Go, Collect $200” card. Real estate investment trusts — well-loved by investors for their… Read More
Analyst Articles
When you voluntarily cease doing business with your biggest customer, you best have a good explanation. If not, then investors will think you’re nuts — and dump your stock. But car battery maker Exide Technologies (Nasdaq: XIDE) had a good excuse. The company’s biggest customer, Wal-Mart (NYSE: WMT) made life… Read More
Here’s Why I Think Shares of Ford Could Jump 50%
Many of you invest right alongside me and my $100,000 Real-Money Portfolio. And since your money is at stake here, along with the $100,000 in real money that StreetAuthority has given me to invest, I’m constantly monitoring my holdings. As some of you may have noticed, there’s… Read More
These Small Stocks Could Provide BIG Gains Very Soon
Investors focused on larger companies saw their ups and downs in 2011. Rather than focus on the usual suspects, perhaps they should have been focused on antimony. It’s an obscure — and toxic — element that has some appealing industrial applications such as flame retardants and in solder and ball… Read More
4 Stocks That Could Easily Double Dividends
As an income investor, my favorite combination is a high-yielding stock poised for above-average dividend growth. Fortunately, these stocks aren’t that difficult to find if you know what to look for. I find the best dividend growth prospects are companies with… Read More
We’re Investing $100,000 Right Here
Unless you frequent our website, StreetAuthority.com, I’d guess you’ve never heard of David Sterman. That’s about to change… Dave has worked as an investment analyst for nearly two decades. He started his career in equity research at Smith Barney, culminating in a position as… Read More
The Best Way to Invest in Biotech Stocks
The appeal of finding the right biotech stock is self-evident. If you get it right, and a cutting-edge biotech scores a major win with a breakthrough drug treatment, then you can score huge gains. Last month, I reviewed my performance over the course of 2011 in hopes… Read More
I Wouldn’t Recommend This Stock to ANYONE
Finally, the stock market and economy are doing noticeably better. Perhaps the most welcome sign is unemployment, which has gradually worked its way down to 8.5% from a recession high of… Read More
3 Companies That Are Blowing the Top Off Estimates
Depending on your area of focus, earnings season is either well underway or hasn’t even started yet. Many large-cap stocks have weighed in, and almost half of the S&P 500 will have delivered quarterly results by the end of this week. Most… Read More
The Market Leader in a Fast-Growing Industry
We humans are pretty predictable. We live our lives in certain patterns and according to certain preferences. There was a time when no one knew what those preferences were. The guy taking my order at a restaurant might remember I like Diet Coke, or the mechanic might… Read More